FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2760987813> ?p ?o ?g. }

• W2760987813 endingPage "117955491773344" @default.
• W2760987813 startingPage "117955491773344" @default.
• W2760987813 abstract "Introduction: Reduction in bone mineral density (BMD) is a common side effect of androgen deprivation therapy (ADT). We aimed to examine the cross-sectional and longitudinal variation in BMD and associated bone markers in patients with nonmetastatic prostate cancer (PCa) managed with and without ADT. Methods: Bone mineral density of the total body, lumbar spine, femoral neck, ultradistal forearm, and one-third distal radius was measured in 88 patients with PCa without bone metastases at baseline and at 6 months. Patients were categorized into 4 groups: (1) acute ADT (≤6 months), (2) chronic ADT (>6 months), (3) former ADT, and (4) no ADT (controls). Serum levels of bone metabolism markers, procollagen type I N-terminal propeptide (PINP) and C-terminal cross-linking telopeptide of type I collagen (CTX), were also measured. Results: In the cross-sectional analysis, men receiving chronic ADT had significantly lower total body BMD as compared with former ADT users and men with no ADT. In longitudinal analysis, a significant reduction in ultradistal forearm BMD was observed in both acute and chronic ADT users after 6 months (4.08% and 2.7%, P = .012 and .026, respectively). A significant reduction in total body BMD was observed in acute ADT users (2.99%, P = .032). Former ADT users had a significant increase in both lumbar spine and femoral neck BMD (2.84% and 1.59%, P = .008 and .002, respectively). The changes in BMD were not significantly different between acute and chronic ADT users. In the cross-sectional analysis, higher levels of PINP and CTX were observed in acute and chronic ADT users than former ADT users or PCa controls. In longitudinal analysis, the level of serum PINP and CTX did not change significantly from baseline to 6 months in acute, chronic, and former ADT users, or PCa controls, and the percentage change did not differ among the 4 groups. Conclusions: Men on acute ADT had a similar rate of bone loss to men on chronic ADT. Reversibility in ADT-induced bone loss was observed in those who discontinued ADT. Serum levels of PINP and CTX were higher in acute and chronic ADT users and levels returned to the range of PCa controls when treatment was withdrawn." @default.
• W2760987813 created "2017-10-20" @default.
• W2760987813 creator A5008047924 @default.
• W2760987813 creator A5020173949 @default.
• W2760987813 creator A5021005690 @default.
• W2760987813 creator A5022138320 @default.
• W2760987813 creator A5038633379 @default.
• W2760987813 creator A5040255059 @default.
• W2760987813 creator A5045581288 @default.
• W2760987813 creator A5047947605 @default.
• W2760987813 creator A5048716954 @default.
• W2760987813 creator A5049206352 @default.
• W2760987813 creator A5057733198 @default.
• W2760987813 creator A5069303588 @default.
• W2760987813 creator A5082958479 @default.
• W2760987813 creator A5090233891 @default.
• W2760987813 date "2017-01-01" @default.
• W2760987813 modified "2023-10-11" @default.
• W2760987813 title "Effect of Androgen Deprivation Therapy on Bone Mineral Density in a Prostate Cancer Cohort in New Zealand: A Pilot Study" @default.
• W2760987813 cites W1490585737 @default.
• W2760987813 cites W1918781548 @default.
• W2760987813 cites W1980550139 @default.
• W2760987813 cites W1990229954 @default.
• W2760987813 cites W1990869186 @default.
• W2760987813 cites W2001372146 @default.
• W2760987813 cites W2008795349 @default.
• W2760987813 cites W2011444134 @default.
• W2760987813 cites W2017916933 @default.
• W2760987813 cites W2019530713 @default.
• W2760987813 cites W2021551674 @default.
• W2760987813 cites W2025317506 @default.
• W2760987813 cites W2035837990 @default.
• W2760987813 cites W2043150075 @default.
• W2760987813 cites W2045981419 @default.
• W2760987813 cites W2051963354 @default.
• W2760987813 cites W2054713307 @default.
• W2760987813 cites W2056225645 @default.
• W2760987813 cites W2076445987 @default.
• W2760987813 cites W2094853969 @default.
• W2760987813 cites W2104346064 @default.
• W2760987813 cites W2111758990 @default.
• W2760987813 cites W2129550487 @default.
• W2760987813 cites W2140757280 @default.
• W2760987813 cites W2170480609 @default.
• W2760987813 cites W2172242835 @default.
• W2760987813 cites W2315115941 @default.
• W2760987813 cites W2582192498 @default.
• W2760987813 doi "https://doi.org/10.1177/1179554917733449" @default.
• W2760987813 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5638161" @default.
• W2760987813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29051709" @default.
• W2760987813 hasPublicationYear "2017" @default.
• W2760987813 type Work @default.
• W2760987813 sameAs 2760987813 @default.
• W2760987813 citedByCount "16" @default.
• W2760987813 countsByYear W27609878132018 @default.
• W2760987813 countsByYear W27609878132019 @default.
• W2760987813 countsByYear W27609878132020 @default.
• W2760987813 countsByYear W27609878132021 @default.
• W2760987813 countsByYear W27609878132022 @default.
• W2760987813 countsByYear W27609878132023 @default.
• W2760987813 crossrefType "journal-article" @default.
• W2760987813 hasAuthorship W2760987813A5008047924 @default.
• W2760987813 hasAuthorship W2760987813A5020173949 @default.
• W2760987813 hasAuthorship W2760987813A5021005690 @default.
• W2760987813 hasAuthorship W2760987813A5022138320 @default.
• W2760987813 hasAuthorship W2760987813A5038633379 @default.
• W2760987813 hasAuthorship W2760987813A5040255059 @default.
• W2760987813 hasAuthorship W2760987813A5045581288 @default.
• W2760987813 hasAuthorship W2760987813A5047947605 @default.
• W2760987813 hasAuthorship W2760987813A5048716954 @default.
• W2760987813 hasAuthorship W2760987813A5049206352 @default.
• W2760987813 hasAuthorship W2760987813A5057733198 @default.
• W2760987813 hasAuthorship W2760987813A5069303588 @default.
• W2760987813 hasAuthorship W2760987813A5082958479 @default.
• W2760987813 hasAuthorship W2760987813A5090233891 @default.
• W2760987813 hasBestOaLocation W27609878131 @default.
• W2760987813 hasConcept C121608353 @default.
• W2760987813 hasConcept C125870589 @default.
• W2760987813 hasConcept C126322002 @default.
• W2760987813 hasConcept C126894567 @default.
• W2760987813 hasConcept C131075544 @default.
• W2760987813 hasConcept C134018914 @default.
• W2760987813 hasConcept C143998085 @default.
• W2760987813 hasConcept C160160445 @default.
• W2760987813 hasConcept C170033053 @default.
• W2760987813 hasConcept C181199279 @default.
• W2760987813 hasConcept C185592680 @default.
• W2760987813 hasConcept C2775854910 @default.
• W2760987813 hasConcept C2776541429 @default.
• W2760987813 hasConcept C2776886416 @default.
• W2760987813 hasConcept C2777899217 @default.
• W2760987813 hasConcept C2779329777 @default.
• W2760987813 hasConcept C2780192828 @default.
• W2760987813 hasConcept C55493867 @default.
• W2760987813 hasConcept C71924100 @default.
• W2760987813 hasConcept C72563966 @default.
• W2760987813 hasConceptScore W2760987813C121608353 @default.
• W2760987813 hasConceptScore W2760987813C125870589 @default.

• next